HEcoPerMed, personalized medicine from a health economic perspective: lessons learned and potential opportunities ahead

Per Med. 2023 Jul;20(4):299-303. doi: 10.2217/pme-2022-0074. Epub 2023 Sep 22.
No abstract available

Keywords: cancer; cost; cost effectiveness; diabetes; health economics; health outcome; histology-independent; pharmacogenomics; quality adjusted life year; tumor-agnostic.

Publication types

  • Editorial